150 related articles for article (PubMed ID: 369586)
21. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 1. Detection of cellular sensitization of peripheral blood lymphocytes using the LAI test].
Ludwig HJ; Storch H
Zentralbl Gynakol; 1986; 108(10):593-606. PubMed ID: 3526755
[TBL] [Abstract][Full Text] [Related]
22. Effect of serum factors and cell washings on leukocyte adherence inhibition in breast cancer patients.
Fujisawa T; Waldman SR; Yonemoto RH
Gan; 1980 Apr; 71(2):165-72. PubMed ID: 7009300
[TBL] [Abstract][Full Text] [Related]
23. Blocking of the response by human T-lymphocytes to extracts of autologous cancer by monoclonal antibody to Class-I major histocompatibility complex gene products in the leukocyte adherence inhibition assay.
Shenouda G; Thomson DM
Cancer Res; 1984 Jul; 44(7):2762-8. PubMed ID: 6609766
[TBL] [Abstract][Full Text] [Related]
24. Specific immunodiagnosis of hepatoma by tube leukocyte adherence inhibition assay and a modified method of repeated tube leukocyte adherence inhibition assay.
Morizane T; Kumagai N; Tsuchimoto K; Watanabe T; Tsuchiya M
Cancer Res; 1980 Aug; 40(8 Pt 1):2928-34. PubMed ID: 6248217
[TBL] [Abstract][Full Text] [Related]
25. Prospective evaluation of the leukocyte adherence inhibition (LAI) test in breast cancer using a panel of extracts from known and unknown primary tumors.
Fritze D; Fedra G; Kaufmann M
Int J Cancer; 1982 Mar; 29(3):261-4. PubMed ID: 7040260
[TBL] [Abstract][Full Text] [Related]
26. Microplate leucocyte adherence inhibition (LAI) assay in pancreatic cancer: detection of specific antitumor immunity with patients' peripheral blood cells and serum.
Goldrosen MH; Dasmahapatra K; Jenkins D; Howell JH; Arbuck SG; Moore MC; Douglass HO
Cancer; 1981 Mar; 47(6 Suppl):1614-9. PubMed ID: 6168355
[No Abstract] [Full Text] [Related]
27. [Modification of leucocyte adherence inhibition (LAI) assay with 51Cr-labelled leucocytes (author's transl)].
Varga A; Stosiek P; Kasper M
Allerg Immunol (Leipz); 1980; 26(2):171-8. PubMed ID: 6449844
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of leukocyte adherence inhibition (LAI) test in primary and secondary hepatic malignancies.
Tantry BV; Jain AK; Gupta S; Gupta JP
J Surg Oncol; 1984 Nov; 27(3):159-62. PubMed ID: 6092784
[TBL] [Abstract][Full Text] [Related]
29. Immunity to tumor-associated antigens in vasectomized men.
Anderson DJ; Alexander NJ; Fulgham DL; Vandenbark AA; Burger DR
J Natl Cancer Inst; 1982 Sep; 69(3):551-5. PubMed ID: 6180209
[TBL] [Abstract][Full Text] [Related]
30. Immune responses in lung cancer patients measured by a modified leukocyte adherence inhibition test using serum.
Sanner T; Kotlar HK; Eker P
Cancer Lett; 1980 Feb; 8(4):283-90. PubMed ID: 6989487
[TBL] [Abstract][Full Text] [Related]
31. Leucocyte adherence inhibition assay for immunodiagnosis of hepatocellular carcinoma.
Onji M
Gastroenterol Jpn; 1984 Aug; 19(4):336-43. PubMed ID: 6092190
[TBL] [Abstract][Full Text] [Related]
32. Automated leucocyte adherence inhibition testing in patients with colorectal cancer.
McLeod DK; Isbister WH
Immunol Cell Biol; 1987 Oct; 65 Pt 5():377-85. PubMed ID: 3325409
[TBL] [Abstract][Full Text] [Related]
33. Humoral antitumor immune responses in patients with breast cancer measured with the leukocyte adherence inhibition technique.
Kotlar HK; Sanner T
J Natl Cancer Inst; 1981 Feb; 66(2):265-71. PubMed ID: 7005505
[TBL] [Abstract][Full Text] [Related]
34. Effector lymphocyte response to homologous tumor antigens in various stages of malignant disease as monitored by leukocyte adherence inhibition--cell mediated immunity (LAI-CMI).
Tsang PH; Roboz JP; Holland JF; Bekesi JG
Immunol Lett; 1988 Jan; 17(1):63-70. PubMed ID: 3280478
[TBL] [Abstract][Full Text] [Related]
35. Comparison by leukocyte adherence inhibition of human immune response to cancer-associated immunogens, Thomsen-Friedenreich (T) and Tn, myelin basic protein, and organ-specific cancer neoantigens.
Thomson DM; Springer GF; Desai PR; Scanzano R; Gubersky M; Shenouda G
Clin Immunol Immunopathol; 1988 Nov; 49(2):231-41. PubMed ID: 2458874
[TBL] [Abstract][Full Text] [Related]
36. A comparison between the macrophage migration inhibition test (MMI) and the leucocyte adherence inhibition test (LAI) in patients with melanoma and carcinoma of the colon.
Isbister WH
N Z Med J; 1978 Oct; 88(622):327-30. PubMed ID: 366475
[TBL] [Abstract][Full Text] [Related]
37. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
Okada Y
Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
[TBL] [Abstract][Full Text] [Related]
38. Detection of ovarian cancer by the humoral leukocyte adherence inhibition test using a purified tumor-associated antigen.
Kotlar HK; Knauf S; Beecham J; Kjørstad K; Sanner T
Eur J Cancer Clin Oncol; 1985 Apr; 21(4):483-6. PubMed ID: 3891363
[TBL] [Abstract][Full Text] [Related]
39. Regulation of leukocyte glass adherence and tube leukocyte adherence inhibition (LAI) reactivity by serum factors in dogs with progressing or spontaneously regressing canine transmissible venereal sarcoma (CTVS).
Harding MW; Yang TJ
Cancer Immunol Immunother; 1985; 19(3):168-76. PubMed ID: 3891077
[TBL] [Abstract][Full Text] [Related]
40. Tube leukocyte adherence inhibition assay for the detection of anti-tumour immunity. II. Monocyte reacts with tumour antigen via cytophilic anti-tumour antibody.
Marti JH; Grosser N; Thomson DM
Int J Cancer; 1976 Jul; 18(1):48-57. PubMed ID: 947860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
